Rosalie Hoyle is finalist for Merck Innovation Cup Competition

May 9, 2023

Her team will pitch a project and business plan to a jury at the competition in Frankfurt, Germany.

A woman stands smiling beside a research poster titled “Naphthoisoquinone Analogues Inhibit Wnt/β-catenin Signaling and Colorectal Cancer Tumorigenesis” at an event. The poster includes graphs, charts, molecular diagrams, and text detailing the study’s findings. The setting appears to be an academic conference or research symposium.

Rosalie Hoyle, a Ph.D. candidate in Medicinal Chemistry, has been selected as a finalist in the Merck Innovation Cup competition next month in Frankfurt, Germany. Her team will pitch a project and business plan to a jury. Last year's competition drew more than 3,500 applicants worldwide, with only 42 finalists. Jiong Li is Rosalie's adviser. Congratulations Rosalie!